ACM
MDT icon

Argyle Capital Management’s Medtronic MDT Stock Holding History

Argyle Capital Management’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.3M Buy
38,060
+800
+2% +$76.6K 1.07% 33
2025
Q4 		$3.58M Buy
37,260
+200
+0.5% +$19.4K 1.2% 30
2025
Q3 		$3.53M Hold
37,060
– – 1.22% 28
2025
Q2 		$3.23M Buy
37,060
+150
+0.4% +$12.7K 1.17% 29
2025
Q1 		$3.32M Buy
36,910
+250
+0.7% +$22.4K 1.23% 31
2024
Q4 		$2.93M Buy
36,660
+2,610
+8% +$226K 1.15% 35
2024
Q3 		$3.07M Sell
34,050
-2,270
-6% -$191K 1.22% 30
2024
Q2 		$2.86M Sell
36,320
-1,600
-4% -$131K 1.18% 30
2024
Q1 		$3.3M Sell
37,920
-2,000
-5% -$171K 1.28% 28
2023
Q4 		$3.29M Sell
39,920
-7,450
-16% -$568K 1.36% 27
2023
Q3 		$3.71M Buy
47,370
+1,500
+3% +$126K 1.36% 26
2023
Q2 		$4.04M Sell
45,870
-600
-1% -$51.7K 1.46% 24
2023
Q1 		$3.75M Buy
46,470
+3,900
+9% +$318K 1.32% 27
2022
Q4 		$3.31M Hold
42,570
– – 1.14% 35
2022
Q3 		$3.44M Buy
42,570
+770
+2% +$69.2K 1.34% 24
2022
Q2 		$3.75M Buy
41,800
+400
+1% +$40.5K 1.35% 27
2022
Q1 		$4.59M Sell
41,400
-2,100
-5% -$222K 1.49% 20
2021
Q4 		$4.5M Sell
43,500
-850
-2% -$98.4K 1.4% 24
2021
Q3 		$5.56M Sell
44,350
-150
-0.3% -$19.4K 1.84% 14
2021
Q2 		$5.52M Hold
44,500
– – 1.79% 13
2021
Q1 		$5.26M Sell
44,500
-150
-0.3% -$17.6K 1.77% 13
2020
Q4 		$5.23M Sell
44,650
-250
-0.6% -$27.5K 1.95% 10
2020
Q3 		$4.67M Hold
44,900
– – 1.91% 11
2020
Q2 		$4.12M Hold
44,900
– – 1.73% 16
2020
Q1 		$4.05M Hold
44,900
– – 1.91% 12
2019
Q4 		$5.09M Hold
44,900
– – 1.81% 12
2019
Q3 		$4.88M Sell
44,900
-300
-0.7% -$31.3K 1.84% 10
2019
Q2 		$4.4M Hold
45,200
– – 1.67% 14
2019
Q1 		$4.12M Sell
45,200
-900
-2% -$80.6K 1.58% 21
2018
Q4 		$4.19M Hold
46,100
– – 1.78% 15
2018
Q3 		$4.54M Hold
46,100
– – 1.7% 14
2018
Q2 		$3.95M Hold
46,100
– – 1.57% 18
2018
Q1 		$3.7M Sell
46,100
-1,000
-2% -$82.5K 1.47% 22
2017
Q4 		$3.8M Hold
47,100
– – 1.42% 25
2017
Q3 		$3.66M Hold
47,100
– – 1.44% 26
2017
Q2 		$4.18M Hold
47,100
– – 1.7% 13
2017
Q1 		$3.79M Hold
47,100
– – 1.55% 20
2016
Q4 		$3.35M Sell
47,100
-2,250
-5% -$177K 1.43% 23
2016
Q3 		$4.26M Sell
49,350
-2,380
-5% -$207K 1.85% 14
2016
Q2 		$4.49M Sell
51,730
-260
-0.5% -$21K 1.91% 14
2016
Q1 		$3.9M Sell
51,990
-1,700
-3% -$128K 1.77% 17
2015
Q4 		$4.13M Sell
53,690
-1,200
-2% -$90.3K 1.9% 13
2015
Q3 		$3.67M Sell
54,890
-3,200
-6% -$236K 1.8% 15
2015
Q2 		$4.3M Sell
58,090
-300
-0.5% -$22.9K 1.97% 10
2015
Q1 		$4.55M Sell
58,390
-550
-0.9% -$41.7K 2.04% 8
2014
Q4 		$4.25M Sell
58,940
-338
-0.6% -$23.5K 1.87% 12
2014
Q3 		$3.67M Sell
59,278
-350
-0.6% -$22.3K 1.69% 20
2014
Q2 		$3.8M Sell
59,628
-182
-0.3% -$11.1K 1.77% 20
2014
Q1 		$3.68M Sell
59,810
-1,000
-2% -$58.3K 1.81% 16
2013
Q4 		$3.49M Sell
60,810
-350
-0.6% -$19.8K 1.76% 18
2013
Q3 		$3.26M Sell
61,160
-50
-0.1% -$2.69K 1.79% 21
2013
Q2 		$3.15M Buy
+61,210
New +$3.03M 1.81% 20

Other funds holding MDT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Argyle Capital Management's MDT Position: Q1 2026 in Review

Argyle Capital Management increased its Medtronic (MDT) stake by 2.1% in Q1 2026, buying an estimated $76.6K and bringing the position to 38,060 shares worth $3.3M. The position accounts for 1.07% of the portfolio, ranked #33.

Argyle Capital Management first reported a position in MDT in Q2 2013 and has held it in 52 quarters since. The position peaked at $5.56M in Q3 2021. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Argyle Capital Management held 38,060 shares of Medtronic worth $3.3M as of Q1 2026.
  • Argyle Capital Management bought 800 Medtronic shares in Q1 2026, an estimated $76.6K.
  • Medtronic made up 1.07% of Argyle Capital Management's portfolio in Q1 2026, its #33 holding.
  • Argyle Capital Management first reported a position in Medtronic in Q2 2013 and has held it in 52 quarters since.
  • Argyle Capital Management's Medtronic position peaked at $5.56M in Q3 2021.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Argyle Capital Management's 13F filing for Q1 2026, filed 28 Apr 2026.